BORTESOMIB NEAPOLIS (bortezomib)

BORTESOMIB NEAPOLIS (bortezomib)
Product Description

Bortezomib NEAPOLIS for Injection is an antineoplastic agent available for intravenous injection (IV) use only.

Each single dose vial contains 3.5 mg of Bortezomib as a sterile lyophilized powder

Les Laboratoires Medis

  • TN
  • 2018
    On CPHI since

Les Laboratoires Medis

  • TN
  • 2018
    On CPHI since

More Products from Les Laboratoires Medis (2)

  • ENOXA (enoxaparin sodium)

    Product ENOXA (enoxaparin sodium)

    ENOXA is a Low Molecular Weight Heparin, in a prefilled seringe. It is the first product in sales in Tunisia
  • EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

    Product EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

    After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.

Les Laboratoires Medis resources (1)